Egerton Capital (UK)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,397,732
| Closed | -$117M | – | 29 |
|
|
2016
Q2 | $117M | Sell |
1,397,732
-3,123,953
| -69% | -$261M | 1.31% | 24 |
|
|
2016
Q1 | $415M | Buy |
4,521,685
+230,218
| +5% | +$21.1M | 3.96% | 10 |
|
|
2015
Q4 | $434M | Sell |
4,291,467
-1,299,329
| -23% | -$131M | 4.5% | 9 |
|
|
2015
Q3 | $549M | Buy |
5,590,796
+1,591,342
| +40% | +$156M | 6.2% | 3 |
|
|
2015
Q2 | $468M | Buy |
3,999,454
+3,209,057
| +406% | +$376M | 5.93% | 3 |
|
|
2015
Q1 | $77.6M | Sell |
790,397
-366,367
| -32% | -$36M | 1.06% | 25 |
|
|
2014
Q4 | $109M | Sell |
1,156,764
-4,542,556
| -80% | -$428M | 1.46% | 24 |
|
|
2014
Q3 | $607M | Sell |
5,699,320
-449,423
| -7% | -$47.8M | 8.16% | 2 |
|
|
2014
Q2 | $510M | Buy |
+6,148,743
| New | +$510M | 8.07% | 2 |
|